(Q63011574)

English

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis (English)

0 references

0 references

0 references

United States of America

0 references

start time

15 January 2018

0 references

end time

April 2019

0 references

number of participants

130

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Orange County Research Center

0 references

research subject recruitment status

completed

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03235024

0 references

(Q63011574)

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)